Precio de cierre
Otros sitios de cotización
|
||
- USD | - |
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Timothy Walbert
CEO | Chief Executive Officer | 57 | 01/06/08 |
Aaron Cox
DFI | Director of Finance/CFO | 41 | 01/04/16 |
Karin Rosen
CTO | Chief Tech/Sci/R&D Officer | 57 | 02/11/20 |
Vikram Karnani
CTO | Chief Tech/Sci/R&D Officer | 49 | 01/07/14 |
Chief Tech/Sci/R&D Officer | 66 | 01/10/16 | |
Jeffrey Sherman
CTO | Chief Tech/Sci/R&D Officer | 69 | 01/06/09 |
Keli Walbert
SAM | Sales & Marketing | - | 01/01/18 |
Comptroller/Controller/Auditor | 45 | 01/02/15 | |
David Caraher
SEC | Corporate Secretary | - | - |
Jane Gonnerman
HRO | Human Resources Officer | - | 01/10/21 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Timothy Walbert
CEO | Chief Executive Officer | 57 | 01/06/08 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 229 378 934 | 226 691 767 ( 98,83 %) | 384 366 ( 0,1676 %) | 98,83 % |
Información de la empresa
Horizon Therapeutics Plc
70 St. Stephen's Green
4, Dublin
+353 1 772 2100
http://www.horizontherapeutics.comEmpresas del grupo
Nombre | Categoría y sector |
---|---|
Horizon Pharma Treasury Ltd.
|
Varia. 1 de ene. | Capi. | |
---|---|---|
+32,20 % | 588 mil M | |
-3,23 % | 364 mil M | |
+19,29 % | 326 mil M | |
+4,81 % | 285 mil M | |
+15,45 % | 239 mil M | |
+10,36 % | 210 mil M | |
-7,24 % | 200 mil M | |
+8,88 % | 167 mil M | |
-0,57 % | 161 mil M |
- Bolsa de valores
- Acciones
- Acción HZNP
- Acción
- Empresa Horizon Pharma Inc